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Pluripotent cells can be derived from fibroblasts by
ectopic expression of defined transcription factors.
A fundamental unresolved question is whether termi-
nally differentiated cells canbe reprogrammed toplu-
ripotency. We utilized transgenic and inducible ex-
pression of four transcription factors (Oct4, Sox2,
Klf4, and c-Myc) to reprogrammouseB lymphocytes.
These factorswere sufficient toconvert nonterminally
differentiated B cells to a pluripotent state. However,
reprogramming of mature B cells required additional
interruption with the transcriptional state maintaining
B cell identity by either ectopic expression of the
myeloid transcription factor CCAAT/enhancer-bind-
ing-protein-a (C/EBPa) or specific knockdown of
the B cell transcription factor Pax5. Multiple iPS lines
were clonally derived from both nonfully and fully
differentiatedB lymphocytes,whichgave rise to adult
chimeras with germline contribution, and to late-term
embryos when injected into tetraploid blastocysts.
Our study provides definite proof for the direct nu-
clear reprogrammingof terminally differentiatedadult
cells to pluripotency.
INTRODUCTION
Embryonic development and cellular differentiation are consid-
ered unidirectional pathways because cells undergo a progres-
sive loss of developmental potency during cell fate specification
(Gurdon, 2006). The success of somatic cell nuclear transfer
(SCNT) experiments in mammalian species provided proof that
the epigenetic state of adult differentiated cells is not fixed but
remains pliable for reprogramming by factors present in the oo-
cyte (Byrne et al., 2007; Jaenisch and Young, 2008; Wakayama
and Yanagimachi, 2001). However, the inefficiency and ethical
concerns associated with attempting to clone human somatic
cells have spurred the field to search for alternative methods to
achieve nuclear reprogramming (Jaenisch and Young, 2008).250 Cell 133, 250–264, April 18, 2008 ª2008 Elsevier Inc.An important breakthrough was achieved by Yamanaka and col-
leagues who succeeded in directly reprogramming fibroblasts
into induced pluripotent stem (iPS) cells by transduction of the
four transcription factors Oct4, Sox2, Klf4 and c-Myc (Takahashi
and Yamanaka, 2006). Although the initially obtained iPS cells
were not normal, several groups have since advanced the direct
reprogramming technique by generating iPS cells that are epige-
netically and developmentally indistinguishable from embryo de-
rived ES cells (Maherali et al., 2007; Okita et al., 2007; Wernig
et al., 2007). Moreover, transgenic expression of c-Myc was
found to be dispensable for reprogramming though it acceler-
ated and enhanced the efficiency of reprogramming (Nakagawa
et al., 2008; Wernig et al., 2008a). Also, the therapeutic potential
of iPS cells was demonstrated in a proof of principle experiment
involving transplantation and gene therapy in models of sickle
cell anemia and Parkinson’s disease (Hanna et al., 2007;
Wernig et al., 2008b). Finally, it has been also shown that human
iPS cells can be generated by transduction of defined factors
into fibroblasts (Park et al., 2008; Takahashi et al., 2007;
Yu et al., 2007).
The conversion of somatic cells to a pluripotent state by SCNT
or by direct in vitro reprogramming posed a number ofmechanis-
tic and technical questions. First, can terminally differentiated
cells be reprogrammed to pluripotency with defined factors,
or can only less differentiated cells such as somatic stem cells,
undergo nuclear reprogramming to pluripotency? (Eggan et al.,
2004;Hochedlinger and Jaenisch, 2002) Recently, successful re-
programming of liver cells that had activated a Cre-recombinase
genedrivenby a transgenic rat albumin enhancer/promoter (Pos-
tic et al., 1999), has been achieved (Aoi et al., 2008). However, as
albumin gene expression marks heterogeneous cells popula-
tions in the liver in addition to hepatocytes (Matthews et al.,
2004; Rountree et al., 2007), including oval cells that play an im-
portant role in liver regeneration and might serve as adult liver
stem cells (Grompe, 2005; Wang et al., 2003), the question of re-
programming terminally differentiated cells remains unresolved.
Moreover, it is unclear whether progressive differentiation of
the donor cells affects the efficiency of in vitro reprogramming.
Development of cells along the B cell lineage allows us to ad-
dress these questions because sequential intrinsic genetic DNA
rearrangements in the heavy and light chain immunoglobulin loci
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genetically mark the different consecutive stages of B cell matu-
ration (Jung et al., 2006). Cells at the Pro-B stage of development
initiate immunoglobulin rearrangements, a process involving the
assembly of V (variable), D (diversity) and J (joining) gene seg-
ments. Assembly of the heavy chain locus (IgH) precedes that
of the light chains loci (IgL) (Jung et al., 2006). In addition, the
rearrangements of the IgH locus are sequential with DH to JH
joining occurring on both alleles prior to VH to DHJH segment
rearrangement (Jung et al., 2006). The productive assembly of
VH-DHJH variable gene region indirectly signals differentiation
to the next stage in which IgL chains are assembled with Igk
rearrangement generally preceding that of Igl (Jung et al.,
2006). To define the susceptibility of differentiated cells to
nuclear reprogramming we used cells from this highly ordered
developmental pathway that carry distinct, sequentially acquired
genetic ‘‘fingerprints’’ that would allow accurate retrospective
assessment of the developmental stage of the donor B cell
nucleus that was able to generate the respective monoclonal
iPS line.
In this study, we have generated iPS cells from pro and pre-
B cells by transduction with the reprogramming factors Oct4,
Sox2, c-Myc and Klf4 and from mature B cells by the additional
overexpression of C/EBPa or specific knockdown of the Pax5
transcription factor. We show that the reprogrammed cells car-
ried the genetic rearrangements characteristic of donor nonter-
minally differentiated and mature terminally differentiated B cells
and were able to generate adult chimeric mice and contribute
to germline. Our results indicate that specific combinations
of reprogramming factors can reset the genome of terminally
differentiated cells to a pluripotent state.
RESULTS
Inducible Expression of Reprogramming
Factors in the B Cell Lineage
Our initial strategy was to determine whether Oct4, Sox2, Klf4
and c-Myc transcription factors, which were shown to be suffi-
cient to reprogrammouse and human fibroblast cultures (Meiss-
ner et al., 2007; Okita et al., 2007; Takahashi et al., 2007; Taka-
hashi and Yamanaka, 2006; Wernig et al., 2007), were capable
of reprogramming cells of the B cell lineage. Because of the
relatively low infectivity of mouse lymphocytes with viruses, we
established a system that allowed inducible transgenic expres-
sion of the four reprogramming factors in B cells. To this end,
we have recently shown that doxycycline-inducible (Dox) lentivi-
ral vectors encoding the Oct4, Sox2, c-Myc and Klf4 transcrip-
tion factors are able to reprogram mouse embryonic fibroblasts252 Cell 133, 250–264, April 18, 2008 ª2008 Elsevier Inc.(MEFs) into stable iPS cells that maintain their pluripotency after
Dox withdrawal (Brambrink et al., 2008). When injected into blas-
tocysts these cells were capable of generating postnatal chi-
meras which contain clonal populations of somatic cells carrying
the identical proviral copies that generated the ‘‘primary’’ iPS
cells (M.W., unpublished data). We reasoned that B cells derived
from these chimeras, when exposed to Dox, might activate the
proviral copies that induced the primary iPS cells and thus might
facilitate reprogramming and the generation of ‘‘secondary’’ iPS
cells (Figure 1A). MEFs carrying a constitutively expressed
reverse tetracycline trans-activator driven by the ROSA26 pro-
moter (R26-M2rtTA) and a knock-in of GFP into the endogenous
Nanog locus (Nanog-GFP) were infected with the Dox-inducible
lentiviral vectors encoding Oct4, Sox2, c-Myc and Klf4 genes
(Brambrink et al., 2008). Colonies appearing after 12 days of
Dox treatment (Figure 1B) were picked and propagated without
Dox to establish Nanog-GFP+ iPS lines (Figure 1C and Figure S1
available online). The MEF derived primary iPS cells were
injected into blastocysts to generate embryonic and adult chi-
meras (Figure 1D). Pro-B and Pre-B cells were isolated from
the bone marrow and mature IgM+IgD+ B cells were purified
from the spleen of 8 week old adult chimeric mice and grown
in media supplemented with hematopoietic cytokines and Dox
for 7 days. Chimeras derived from the MEF-iPS-#1 cell line
were chosen for further study as donor B cells from chimeras in-
duced high expression levels of the 4 factors in the presence of
Dox (Figure 1E).
Reprogramming of Nonterminally Differentiated B Cells
Initial attempts failed to reprogram bone marrow derived B cells
and spleen B cells that had been cultured on irradiated feeder
cells in ES media supplemented with LIF and Dox as the cells
died within five days in culture (data not shown). We reasoned
that addition of cytokines might be necessary to allow for an
initial proliferation of the B cells that would ensure a sufficient
number of cell divisions necessary to initiate epigenetic reprog-
ramming by expression of the four factors. Therefore, we opti-
mized culture conditions that would support immature and
mature B cell growth as well as that of ES cells to ensure viability
during the reprogramming process from B to iPS cells. Cells
were grown on OP9 bone marrow stromal cells in media supple-
mented with LIF which is required for ES cell growth, with IL-7,
SCF and Flt-3L which support B cell development (Milne et al.,
2004), and with IL-4, anti-CD40 and LPS which are important
for proliferation of mature B cells (Hayashi et al., 2005)
(Figure S2). In initial experiments we detected AP positive colo-
nies in cultures of sorted Pre- and Pro-B cell subsets derivedFigure 1. Transgenic Inducible Expression of Oct4, Sox2, Klf4, and c-Myc in the Mouse B Cell Lineage
(A) Schematic drawing representing the strategy used in this study for reprogramming cells from the B cell lineage.
(B) MEFs heterozygous for the ROSA26-M2rtTA and Nanog-GFP alleles were infected with Dox inducible lentiviruses encoding Oct4, Sox2, Klf4, and c-Myc.
Typical morphology of colonies derived from infected MEFs cultured with Dox for 12 days.
(C) ES-like morphology of Nanog-GFP+ MEF derived iPS lines (MEF-iPS#1 cell line is shown). These cell lines were injected into blastocysts to derive embryonic
and adult chimeras.
(D) Different B cell subsets were isolated from embryonic liver or adult spleen and bone marrow tissues and used for reprogramming experiments.
(E) Quantitative RT-PCR assay of viral transgene expression in MEF-iPS#1 chimera derived B cells subsets from bone marrow (BM) or spleen with (4 mg/ml) or
without Dox treatment for 7 days as indicated in the figure. Average relative expression levels and standard deviation from three RT-PCR reactions are shown for
all four factors.
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from 8 week old adult chimera bonemarrow after 14 days of Dox
treatment (Figure 2A). Small flat colonies appeared 3 days after
Dox induction that subsequently underwent robust expansion
(Figure 2B). Around day 11 after Dox induction smooth ES-like
small colonies embedded within the granulated large colonies
were observed which became Nanog-GFP+ at day 14 (Fig-
ure 2B). Colonies were picked 14 days after Dox induction
from 3 independent experiments and grown on MEF feeders in
ES media without Dox. Within 3 passages over 90% of the
picked colonies grew into homogenous ES-like Nanog-GFP+
iPS cells. In the following we will refer to these cell lines as
‘‘iB-iPS’’ cells (for iPS cells derived from ‘‘immature’’ non-fully
differentiated B cells including Pre and Pro B cells).
Genomic DNA harvested from established iB-iPS cell lines
was analyzed by PCR for heavy and light chain rearrangements.
Representative cell lines reprogrammed from the B220+c-Kit+
Pro-B cell subpopulation showed that some iPS lines carried
DH-JH rearrangements (lines #1,2,7, and 9) whereas others did
not show evidence for any IgH rearrangements (lines #3,4, and
6) (Figure 2C), as would be expected for rearrangements in the
donor B cell subset at the Pro B cell stage of development.
Cell lines established from the adult bone marrow derived
B220+CD25+ Pre-B cells carried at least one VH-DJH rearrange-
ment and an additional DH-JH or VH-DJH rearrangement (lines #5
and 8) (Figure 2C), both genetic rearrangements of the IgH locus
typically observed in such B cell populations (Jung et al., 2006).
Rearrangements were verified by Southern blot analysis (Fig-
ure S3). For subsequent analysis, we focused on cell lines that
contained genetic evidence for IgH rearrangements, as only
those can be definitively traced to cells committed to the B cell
lineage. All iB-iPS cell lines stained positive for the ES markers
AP, SSEA1 and Oct4 and generated differentiated teratomas
(Figures 2D and S4). Furthermore, we obtained adult chimeras
from several iB-iPS cell lines (Figure 2E and Table S1). Represen-
tative Southern blots of tail DNA from an iB-iPS#8 cell line de-
rived chimera showed an identical heavy chain rearrangement
pattern as the donor iB-iPS cell line (Figure 2F), thus confirming
that the chimera was derived from the respective iB-iPS cell line
and not from contaminating ES or MEF derived iPS cells. A chi-
mera derived from iB-iPS line #9 produced 100%germline trans-
mission (Figures 2G and S5). These results demonstrate that
cells committed to the B cell lineage carrying DH-JH or VH-DJH
rearrangements, although not fully differentiated as they lack
light chain rearrangements, can be reprogrammed to a pluripo-
tent ES-like state by the induction of the 4 transcription factors
Oct4, Sox2, Klf4 and c-Myc.254 Cell 133, 250–264, April 18, 2008 ª2008 Elsevier Inc.Reprogramming of Terminally Differentiated B Cells
We failed to generate any reprogrammed AP+ colonies fromma-
ture spleen B cells or bone marrow derived Igk+ cells in 3 inde-
pendent experiments (Figure 2A). This was puzzling given that
IgM+IgD+ mature transgenic B cells could be maintained in
our culture conditions for up to 6 weeks and continued to
express B cell markers (Figure S2). We tested, therefore, the
hypothesis that additional pluripotency factors might be needed
to achieve reprogramming of mature B cells. Dox induced
IgM+IgD+ spleen B cells obtained from adult transgenic chi-
meras were infected with combinations of retroviruses encoding
20 different pluripotency factors, that were originally generated
to screen for fibroblast reprogramming (Takahashi and Yama-
naka, 2006). Yet, these experiments repeatedly yielded negative
results (Figure 3A).
As an alternative approach, we aimed to ‘‘sensitize’’ the B cells
to respond to Dox dependent 4-factor induction by altering their
mature B cell identity. It has been shown that overexpression of
the myeloid transcription factor CCAAT/enhancer-binding pro-
tein-a (C/EBPa) is able to reprogram B cells into macrophage-
like cells (Xie et al., 2004) by disrupting the function of Pax5,
a transcription factor that is a master regulator of mature B cell
development and function (Cobaleda et al., 2007b). We tested,
therefore, whether transduction with C/EBPa would facilitate re-
programming of mature B cells. Adult spleen B cells derived from
10 week-old chimeras were transduced with a retrovirus encod-
ing C/EBPa and/or the IL7-Ra subunit and cultured on OP9 cells
in the presence of Dox to induce the four factors Oct4, Sox2, Klf4
and c-Myc. Figure 3A shows that AP positive colonies appeared
after 14 days in culture in cells transduced with C/EBPa or with
C/EBPa and IL7-Ra but not in cells transduced with IL7-Ra
alone. Infection of transgenic B cells with C/EBPa did not result
in altering the induction levels of transgenic factors upon treat-
ment with Dox (Figure S6). After 3 days of growth on OP9, small
adherent colonies were formed which continued to grow into
denser granulated colonies (Figure 3B). Small round ES-like col-
onies appeared within the large dense granulated colonies, and
Nanog-GFP+ foci were readily detected at approximately day 14
(Figures 3B and S7). Colonies isolated at day 14 were passaged
onMEF feeder cells without hematopoietic cytokines or Dox and
within 3 passages all lines assumed an ES-like morphology and
were positive for the Nanog-GFP marker (Figure 3C). Our results
suggest that transduction with C/EBPa can sensitize mature
B cells to respond to the expression of Oct4, Sox2, c-Myc and
Klf4 and re-express pluripotency markers. We established 120
iPS lines that were picked from independent tissue culture wellsFigure 2. Reprogramming of Nonterminally Differentiated B Cells to Pluripotency
(A) 8-week-old chimera derived bone marrow B cell subsets (50*10^3 cells per well) and spleen IgM+IgD+ mature B cells (250*10^3 spleen cells per well) were
plated on OP9 bone marrow stroma with conditioned media and Dox. After 14 days plates were fixed and stained for AP activity.
(B) Images for characteristic colonies at different time point obtained from sorted B220+CD25+ bone marrow cells.
(C) PCR analysis for rearrangements in selected iB-iPS. MEFs and splenocytes were used as negative and positive controls, respectively.
(D) Immunostaining for ES cell markers on a representative line iB-iPS#8.
(E) A chimeric mouse from iB-iPS #8 cell line. Agouti colored hairs originate from injected iPS lines.
(F) Southern blot analysis of iB-iPS line #8 grown on MEF feeders and of tail tip biopsy taken from the derived chimera. MEF and spleen B cells were used as
negative and positive controls, respectively, for rearrangement detection. Red arrows indicate the two rearranged heavy chain alleles. GL indicates germline frag-
ment representing nonrearranged configuration of the Igh locus.
(G) An adult old chimeric pseudo-male mouse from iB-iPS #9 cell line was mated with Balb/C females and repeatedly achieved 100% germline transmission, as
indicated by the agouti color of all litters obtained.
Figure 3. Reprogramming of Terminally Differentiated Mature B Cells to Pluripotency
(A) IgM+IgD+ cells were isolated from spleen of a 10week old chimera, infected for 24 hr with viral supernatants of retroviruses encoding different combinations of
transcription factors and were transferred afterwards to OP9 coated wells and grown in conditioned media in the presence of Dox. ‘‘20 factors’’ indicate pMXs
based constructs previously used to reprogram mouse fibroblasts as indicated in the Experimental Procedures section. After 14 days of Dox induction and
additional viral transduction as indicated for each well, cells were stained for AP. One out of three independent experiments using different combinations of
factors is shown.
(B) Representative images of colonies at different time points after infection with C/EBPa retrovirus and Dox induction of chimeric spleen derived IgM+IgD+
mature B cell cultures.
(C) Representative pictures of changes in cell morphology after passaging picked colonies at day 14 from IgM+IgD+ B cell cultures infected with C/EBPa and
treated with Dox.containing IgM+IgD+ B cells from adult spleen and lymph nodes
at 14 days after Dox addition and C/EBPa transduction, and
9 cell lines were selected for in depth characterization (Lines
1-6 obtained from adult spleen and 7-9 from adult lymph nodes).
In the following we will refer to these cell lines as ‘‘B-iPS’’ cells
(iPS cells derived from mature ‘‘B’’ cells).
Next, we characterized marker expression, DNA methylation
and histone marks of the B-iPS cell lines. Immunoflorescencestaining showed that all B-iPS cell lines uniformly expressed
ES cell markers AP, SSEA1 antigen, Oct4 and were positive for
Nanog-GFP (Figure 4A). Gene expression analysis showed that
B-iPS and ES cells, but not primary B cells, expressed compara-
ble levels of Nanog, Ecat1, Rex1, Zfp296 and GDF3 genes (Fig-
ure 4B). Bisulphite sequencing was performed to determine the
methylation status of Oct4 and Nanog gene promoters for iB-iPS
and B-iPS cell lines. As expected, fibroblast and B cell controlCell 133, 250–264, April 18, 2008 ª2008 Elsevier Inc. 255
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samples displayed extensive methylation at both promoters,
whereas B-iPS and iB-iPS lines showed widespread demethyla-
tion of these regions similar to that seen in ES cells (Figure 4C).
To assess the chromatin state of the cells, chromatin immuno-
percipitation (ChIP) and real time PCR were performed to quan-
tify ‘active’ histone H3 lysine 4 trimethylation (H3K4me3) and
‘repressive’ histone H3 lysine 27 trimethylation (H3K27me3)
methylation marks on a selected set of genes known to be biva-
lent in ES cells (Bernstein et al., 2006). The promoter region
for the B cell transcription factor gene Pax5 displayed strong en-
richment for H3K4me3 methylation in the donor mature B cells,
whereas H3K27me3 methylation predominated at the silent
genes Zfpm2 and Irx2 (Figure 4D). Conversely, all these genes
carry equivalent enrichment for both histone modifications in
B-iPS and ES cells, consistent with the notion that these bivalent
domains were re-established during reprogramming (Figure 4D).
Rearrangements of Immunoglobulin Loci in B-iPS Cells
Confirm Mature B Cell Identity of the Donor Cells
In order to characterize the genomic rearrangements of the Ig
loci in the B-iPS cells, genomic DNA from MEF depleted iPS
cell lines grown on gelatin was analyzed for IgH, Igk and Igl
rearrangements by complementary approaches that included
Southern blotting, PCR and sequencing of individual PCR
fragments (Alt et al., 1981; Chang et al., 1992; Cobaleda et al.,
2007a; Lewis et al., 1982; Schlissel et al., 1991) (Table S2). All
cell lines contained 2 heavy chain rearrangements: one was
a productive in-frame V-DJ rearrangement whereas the other
was either a frozen D-J rearrangement or a nonproductive
V-DJ rearrangement (Figures 5A–5C, lanes 1–9, and 5D). These
results are consistent with the well established observation that
adult mature B cells in the periphery have 2 rearranged heavy
chain loci (Jung et al., 2006). As predicted for mature B cells,
the light chain loci had one productive in frame Igk or Igl light
chain rearrangement (Figure 5A–5C, lanes 1–9, and 5D and 5E)
(Jung et al., 2006). B-iPS#9 was derived from a minor B cell
subpopulation with a rearranged productive Igl chain and kappa
locus that was retained in the germline configuration (Figures 5C
and 5E, lane 9) (Nadel et al., 1990; Oberdoerffer et al., 2003). Fi-
nally, sequences obtained from heavy and light chain rearrange-
ments from B-iPS cell line #4 provided conclusive evidence that
the donor B cell nucleus that yielded this cell line had undergone
somatic hypermutation (Figure 5F), a process that occurs after
antigen encounter in vivo and involves acquiring a high rate of
somatic mutations at ‘‘hotspots’’ located throughout the DNA
encoding the immunoglobulin variable region (Teng and Papava-
siliou, 2007). The abundance of mostly nonsilent mutations in
the variable region of the productive rearrangements in this cell
line (Figure 5F) shows that nonnaive B cells that have alreadyencountered antigen in vivo are also amenable to direct reprog-
ramming. Finally, the C/EBPa viral transgene was detected in
genomic DNA from all B-iPS cell lines analyzed (Figure 5G).
Developmental Potential of B-iPS Cells
As an initial test for developmental potency we injected 8 B-iPS
cell lines subcutaneously into immunodeficient (SCID) mice. Six
weeks after injection, macroscopic teratomas were observed in
all injected mice. Histological examination showed that the tera-
tomas contained cell types representing all three embryonic
germ layers (Figure 6A). To assess more stringently their devel-
opmental potential, individual B-iPS cell lines were injected
into diploid (2N) blastocysts resulting in the generation of viable,
high-contribution chimaeras from all 4 B-iPS cell lines tested
(Figure 6B and Table S1). Southern blot analysis of genomic
DNA isolated from B-iPS #4 and #1 derived chimeras revealed
the presence of genomic fragments corresponding to rear-
ranged Igk alleles identical to those observed in the donor in-
jected B-iPS cell lines (Figures 6C and S8, respectively). Impor-
tantly, the B-iPS#1 cell line contributed to the germline as was
evident by the derivation of offspring carrying a constitutively ex-
pressed lentiviral transgene EGFP vector that was used for
transducing B-iPS#1 cells prior to blastocyst injections (Fig-
ure 6D). Southern blot analysis confirmed segregation of the
rearranged Igk allele found in the donor B-iPS line in the GFP+
derived mice (Figure S9).
The generation of mice by tetraploid complementation, which
involves injection of pluripotent cells in 4N host blastocysts,
represents the most rigorous test for developmental potency
because the resulting embryos are derived only from injected
donor cells (Eggan et al., 2001). Both B-iPS lines tested (#4
and #9) were able to generate mid- and late-gestation ‘all
B-iPS embryos’ after injection into 4N blastocysts (Figures 6E
and S10). Sensitive PCR analysis for the detection of a 2Kb
germ-line region from the B cell receptor heavy chain locus
that is lost upon initiation of genetic rearrangement (Chang
et al., 1992) shows that genomic DNA from B-iPS #4 cell line em-
bryos derived by tetraploid complementation had lost the germ
line band and carried only the D-J rearrangement as predicted
from the repertoire in the donor nucleus (Figure 6F, compare to
Figures 5C and 5D–5J rearrangement, lane 4). This conclusion
was confirmed by Southern blot analysis of genomic DNA from
a day E14.5 tetraploid embryo obtained from B-iPS#4 demon-
strating two rearranged Igk locus alleles, without any evidence
for a germline allele (Figure 6C).
We next tested the ability of reprogrammed mature B cells to
generate monoclonal B cells in vivo as a result of the restrictions
imposed by their pre-rearranged IgH and IgL loci (Hochedlinger
and Jaenisch, 2002; Inoue et al., 2005; Oberdoerffer et al., 2003).Figure 4. Marker Expression and Promoter Methylation Analysis of B-iPS Lines
(A) Immunoflorescence staining for ES pluripotency markers Oct4, Nanog (signal obtained from GFP cassette knocked in the endogenous Nanog locus), SSEA1
and AP.
(B) RT-PCR analysis of selected ES marker genes in B cells, ES cells, MEF-iPS cells and different iB-iPS and B-iPS lines.
(C) Analysis of the methylation state of the Oct4 and Nanog promoters using bisulphate sequencing. Open squares indicate unmethylated and filled squares
methylated CpG dinucleotides.
(D) Real-time PCR after chromatin immunoprecipitation using antibodies against H3K4me3 and H3K27me3. Shown are the Log2 enrichments for several
previously reported ‘‘bivalent’’ loci in ES cells.Cell 133, 250–264, April 18, 2008 ª2008 Elsevier Inc. 257
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To facilitate the isolation of B-iPS derived cells in chimeric mice,
B-iPS lines # 4 and 9 were labeled with the GFP marker by lenti-
viral vector mediated transduction prior to blastocyst injection.
Surface expression of Igk and Igl light chain proteins expressed
on CD19+ cells purified from peripheral blood was evaluated by
FACS staining. All GFP+ B cells in B-iPS #4 derived chimeras ex-
pressed Igk chain, but not Igl protein (Figure 6G), consistent with
the genetic analysis that showed a functional Igk light chain rear-
rangement in this cell line (Figures 5B and 5C, lane 4). In contrast,
B-iPS #9 cell line derived B cells carried only a functional Igl light
chain rearrangement (Figure 6G), consistent with the analysis in
Figure 5C (Lane 9). Moreover, we established pluripotent B-iPS
lines from mature adult B cells by specific knockdown of Pax5
transcription factor in B cells and subsequent Dox induction
of the transgenic B cells obtained from iPS derived chimeras
(Figure S11). Finally, two B-iPS cell lines that were generated
by direct infection of genetically unmodified mature B cells
with the Oct4, Klf4, Sox2, c-Myc and C/EBPa (Figure S12). In
summary, our results provide unequivocal molecular and func-
tional proof that mature B cell donor nuclei that contain func-
tional light and heavy chain rearrangements were reprogrammed
to pluripotency.
Efficiency of Reprogramming Mature
Adult B Cells to Pluripotency
To estimate the reprogramming efficiency of mature adult B cells
to pluripotency, a large starting pool of CD19+ B cells isolated
from the spleen of adult chimeras was infected with a C/EBPa
encoding retrovirus carrying a neomycin resistance gene. After
24 hr, IgM+IgD+ B cells were plated as single cells in 96 well
plates on OP9 stromal cells in cytokine conditioned medium in
the presence of Dox and LIF. Five days after plating puromycin
and neomycin were added to the culture medium in order to se-
lect for transgenic B cells that had also been infected with C/
EBPa (Figure 7A). At day 20, wells that showed cell growth
were screened by FACS for detection of Nanog-GFP+ cells
(Figure S13). Wells that scored positive were expanded and
Nanog-GFP iPS cells appeared within 3 passages. PCR analysis
of B-iPS lines obtained confirmed that all cell lines obtained from
two independent experiments originated from C/EBPa infected
mature B cells that had distinct B cell receptor rearrangements
(Figure 7B). Based on these data, we were able to calculatethe efficiency of reprogramming by dividing the number of
GFP+ wells obtained (output) by the number of C/EBPa infected
transgenic B cell containing wells (puromycin and neomycin
double resistant wells = input). This calculation suggested that
the relative efficiency for direct reprogramming of mature B cells
was approximately 1 in 30 cells (Figure 7C). We attribute the rel-
atively high efficiency of reprogramming, compared to previ-
ously reported reprogramming efficiencies between 0.001% to
0.5% (Meissner et al., 2007; Wernig et al., 2007), to the strong
Dox-mediated induction of 4 out of the 5 ectopically expressed
factors that did not rely on retroviral vector infection and random
proviral integrations.
DISCUSSION
Nuclear reprogramming, which pertains to the concept of rewir-
ing the epigenetic state of a somatic nucleus to that of another
cell type, can be achieved by different approaches. The most
recently established strategy to reprogram somatic cells to plu-
ripotency involves direct ectopic expression of defined tran-
scription factors in somatic cells (Okita et al., 2007; Takahashi
and Yamanaka, 2006; Wernig et al., 2007). This enforced factor
expression appears to initiate a sequence of stochastic events
occurring over a relatively extended time period in culture that
eventually leads to generation of a small fraction of cells that
have acquired a stable pluripotent state (Jaenisch and Young,
2008). The transduced factors are required for an initial period
of time in the reprogramming process (Brambrink et al., 2008;
Stadtfeld et al., 2008) during which theymay interact with endog-
enous pluripotency genes (Boyer et al., 2005; Loh et al., 2006)
and gradually induce epigenetic changes that subsequently sus-
tain a stable epigenetic state that is indistinguishable from that of
inner cell mass derived ES cells. During this process, the de novo
methyltransferases Dnmt3a and Dnmt3b also become activated
and in turn methylate and silence the virally transduced factors,
a process that is crucial for subsequent differentiation of the iPS
cells (Brambrink et al., 2008).
Our data provide conclusive evidence that terminally differen-
tiated mature B cells obtained from adult mice can be directly
reprogrammed into ES-like cells in vitro. The donor B cell popu-
lation that eventually underwent successful reprogramming had
completed a complex differentiation pathway involving epigeneticFigure 5. Productive Heavy- and Light-Chain Rearrangements in B-iPS Lines
(A) Genomic DNA from B-iPS lines grown on gelatin was digested with EcoRI and analyzed for V(D)J rearrangements at the Igh locus by Southern blotting using
a 30 JH4 probe.
(B) Vk-Jk rearrangements at the Igk locus were determined by Southern blot analysis of BamHI digested genomic DNA using a 3
0Jk5 probe. (A and B) Any rear-
rangement occurring in these loci abolishes the asterik marked restriction sites of the enzyme used. After rearrangements, the size of the genomic fragment
bound by the probe depends on the next available 50 restriction site in relation to the abolished asterik marked sites. MEFs served as negative control and
CD19+ splenocytes were used as positive controls. GL denotes the position of the germline DNA fragment.
(C) PCR analysis of Vk-Jk and Vl1-Jl light chain rearrangements and of VHQ52-DJH, VH7183-DJH, VHGam3.8-DJH VHJ558-DJH and D-JH rearrangements in se-
lected B-iPS. Rearrangements to different J segments are numbered on the left side of the panels. Detailed characterization of the different immunoglobulin gene
rearrangements by cloning and sequencing was performed to confirm the presence of productive heavy and light chain rearrangements in the cell lines obtained.
Blue arrows indicate ‘‘productive rearrangements’’ and red arrows indicate ‘‘nonproductive rearrangements.’’
(D) Sequences from rearranged IgH and Igk chains from B-iPS line #4 obtained by RT-PCR (Panel C, lane 4). V, D and J segments involved in IgH rearrangement
are indicated, as well as V and J segments from the Igk locus.
(E) Sequencing of the Igl rearrangement (Panel C, lane 9) cloned from B-iPS line #9.
(F) Summary for nonsilent and silent mutations found in the predicted variable region of the encoded B cell receptor as detected by sequencing productive heavy
and light chain rearrangements of B-iPS line #4.
(G) Transgene specific primers were designed and used to detect the presence of C/EBPa provirus in B-iPS lines.Cell 133, 250–264, April 18, 2008 ª2008 Elsevier Inc. 259
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and genetic changes: an initial commitment to the hematopoietic
and subsequently to the B cell lineage; acquisition of productive
heavy and light chain rearrangements; egression from the bone
marrow to repopulate peripheral lymphoid organs in adult
mice, and as observed in one of the cell lines obtained, acquisi-
tion of somatic hypermutations in variable region of B cell recep-
tor genes in response to antigen stimuli.
Importantly, our results demonstrate that under similar induc-
tion levels of Oct4, Sox2, Klf4 and Sox2 transgenes in the B cell
lineage, nonterminally differentiated and terminally differentiated
B cells respond differently to these factors. We observed that ro-
bust reprogramming of fully differentiatedmature B lymphocytes
to pluripotency was achieved following interruption with the
active transcriptional state in mature B cells. This was obtained
either by overexpressing C/EBPa transcription factor, which
normally plays a role in granulocyte cell fate specification (Ramji
and Foka, 2002), or by knockdown of Pax5, a key transcription
factor in B cells. Graf and colleagues (Xie et al., 2004) have
shown that overexpression of C/EBPa converted B cells into
macrophage-like cells by downregulating B cell markers through
inhibition of Pax5 functions. This facilitated extinction of the early
B cell regulators, EBF1 and E2A transcription factors. In addition,
C/EBPa induced upregulation of components of a myeloid tran-
scriptional network (Laiosa et al., 2006; Xie et al., 2004). Bus-
slinger and colleagues have shown that B cells display myeloid
promiscuity of gene expression following deletion of Pax5 in
B lymphocytes, and that such cells can be converted into
macrophage like cells when grown in the presence of myeloid
cytokines (Delogu et al., 2006;Mikkola et al., 2002). These obser-
vations are relevant for understanding the mechanisms of re-
programming. We consider the following mutually nonexclusive
possibilities:
(1) Pax5 deletion has been shown to cause loss of B cell lin-
eage commitment and de-differentiation (Cobaleda et al.,
2007a; Mikkola et al., 2002). C/EBPa may cross-antago-
nize key regulators of the B cell transcriptional network
that maintain the mature B cell identity. This may facilitate
the dedifferentiation of B cells to a less differentiated state
allowing Oct4, Sox2, Klf4 and c-Myc transgene induced
reprogramming. This explanation is consistent with ob-
servations that the differentiation state of the donor cells
is known to influence the efficiency of reprogramming
by nuclear transplantation, as neural and keratinocytestem cells weremore efficiently reprogrammed than other
more differentiated cells obtained from the same lineage
(Blelloch et al., 2006; Li et al., 2007).
(2) C/EBPamay convert mature B cells into macrophage-like
cells (Xie et al., 2004) which have a different epigenetic
state that possibly allows enhanced accessibility to target
genes of Oct4, Sox2, Klf4, and c-Myc that would facilitate
the efficient induction of the endogenous auto-regulatory
loop governing the pluripotent state (Boyer et al., 2005;
Loh et al., 2006). Similarly, loss of Pax5 expression results
in loss of inhibition of key myeloid transcription factors,
and can result in reprogramming B cells into macrophage
like cells (Delogu et al., 2006; Mikkola et al., 2002).
(3) C/EBPa overexpression or Pax5 elimination may enable
mature B cells to transition from a state of growing in sus-
pension to become adherent cells in the presence of OP9
cells, which might be a rate-limiting event in their reprog-
ramming.
(4) Finally, our results do not rule out the possibility that Oct4,
Sox2, Klf4 or c-Myc can be sufficient at very low efficiency
to reprogram mature B cells and that it is feasible that dif-
ferent combinations of factors may be able to reprogram
B lymphocytes under different culture conditions.
The results presented in this study demonstrate that terminally
differentiated cells can be directly reprogrammed to pluripo-
tency by defined factors. At present, somatic cells have been
converted to cells of other germ line lineages only by first reprog-
ramming the cells to a pluripotent embryonic state and then by
differentiation to the different cell type. Whether forced expres-
sion of other factors could ‘‘trans-differentiate’’ terminally differ-
entiated cells to another cell type of a different lineage (e.g., me-
soderm to endoderm or ectoderm) without first passing through
a pluripotent cell stage is presently not known.
EXPERIMENTAL PROCEDURES
Cell Culture and Viral Infections
ES and established iPS cells were cultured on irradiatedMEFs in DME contain-
ing 15% FCS, leukemia inhibiting factor (LIF), penicillin/streptomycin, L-gluta-
mine, beta-mercaptoethanol and nonessential amino acids. MEFs used to
derive primary iPS lines by infectionswith inducible lentiviruseswere harvested
from F1 matings between ROSA26-M2rtTA mice (Beard et al., 2006) and
Nanog-GFP mice (Brambrink et al., 2008). Mouse C/EBPa cDNA was cloned
into the EcoRI cloning site of pLib, MSCV-Neo and pMig retroviral vectors.Figure 6. Developmental Potential of B-iPS Cell Lines
(A) Hematoxylin and eosin staining of a representative teratoma derived from B-iPS line #4.
(B) Adult chimeric mice obtained from B-iPS lines in 2N Balb/C or B6D2F1 host blastocysts.
(C) Southern blot analysis for detection of IgK light chain rearrangements on BamH1 digested genomic DNA (as detailed in Figure 5A) from different tissues
obtained from MEF-iPS #1 derived chimeras (used as negative control) and B-iPS #4 cell line.
(D) B-iPS#1 line was transduced with lentiviral ubiquitin-EGFP vector before injection in 2N blastocysts. Germline transmission was achieved from one of the
chimeras, as we obtained a number of GFP+ embryos, demonstrating the transmission of constitutively expressed EGFP transgene.
(E) ‘‘All B-iPS cell embryos’’ were generated by injection of B-iPS cell into 4N blastocysts. Live E14.5 embryos generated from B-iPS#4 cell lines.
(F) Highly sensitive 50 cycle PCR analysis on 4N embryos obtained from B-iPS#4 for detection of loss of the amplicon representing germline line configuration of
the IgH locus in order to prove that the embryos developed entirely from iPS cells. Equimolar mix of 50 primers DQ52 (recognizes downstream region that is always
excised upon any recombination of the locus) and DSF (degenerate primer recognizing D cassettes) with 30 JH-4 primer. This PCR could yield 4 rearrangement
bands (D-JH1,2,3,4) and a germline 2 Kb band as indicated in the locus scheme.
(G) Immunological analysis for detection of Igk and Igl surface antigen on peripheral blood B cells of chimeras obtained from constitutively GFP labeled B-iPS #4
and #9 (marked with lentiviral ubiquitin-EGFP vector before injection). Presented panels were gated on CD19+ cells and show Igk and Igl expression on iPS
derived B cell (GFP+) and host B cells (GFP-). Green rectangles highlight B-iPS derived of GFP+ B cells.Cell 133, 250–264, April 18, 2008 ª2008 Elsevier Inc. 261
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pMXs vectors encoding ES pluripotency genes were previously described (Ta-
kahashi and Yamanaka, 2006). Lentiviral preparation and infection with Dox in-
ducible lentiviruses encoding Oct4, Klf4, c-Myc and Sox2 cDNA driven by the
TetO/CMV promoter were previously described (Brambrink et al., 2008). Ret-
rovirus stocks were prepared by transient transfection of Phoenix-Eco cells
using Fugene (Roche), and supernatants were harvested 48 hr later. For infec-
tion, purified B cell subsets were resuspended in IMDM with 15% FCS as well
as IL-4, IL-7, Flt-3L, SCF (10ng/ml each, Peprotech), and anti-CD40 (0.1 mg/ml,
BD-Biosciences), LPS (10ng/ml, Sigma-Aldrich) and Dox (4 mg/ml). Then, 2 ml
aliquots were plated onto a 24-well plate precoated with retronectin (Takara)
followed by 2 ml of retrovirus supernatant to which polybrene (Sigma) was
added (8 mg/ml). The plates were incubated at 37C for 2 hr, and afterwards
1ml of viral supernatant was replaced with B cells resuspended in the cytokine
conditioned media described above. Plates were centrifuged for 90 min at
900RPM and then incubated 24 hr. Infected cells were then transferred onto
OP9 bone marrow stromal cells line (ATCC) in fresh cytokine and Dox supple-
mented media. After 14 days on Dox, colonies were picked and cultured on
MEF feeder cells in ES media (without hematopoietic cytokines or Dox) and
in the presence of puromycin (2 mg/ml) to eliminate any remaining OP9 cells.
Pax5 shRNAwas designed using the pSicoOligomaker 1.5which is freely avail-
able at http://web.mit.edu/ccr/labs/jacks/protocols/pSico.html.
V(D)J Rearrangement Analysis
IgH, Igk and Igl rearrangements were amplified by PCR using degenerate
primer sets as previously described (Chang et al., 1992; Cobaleda et al.,
2007a; Schlissel et al., 1991) (Table S2). Rearrangement sequences were an-
alyzed with DNAPLOT search engine (http://www.dnaplot.de). V-DJ and D-J
rearrangements at the Igh locus were detected by Southern blot analysis on
genomic DNA of the indicated iPS lines digested with EcoRI and using a
30JH4 probe (1.6-kb HindIII-EcoRI fragment of plasmid JH4.3) (Alt et al.,
1981). Vk-Jk rearrangements at the Igk locus were determined by Southern
blot analysis of BamHI-digested genomic DNA using a 30Jk5 probe (1-kb
XbaI-EcoRV fragment of plasmid pBS-JkMAR) (Lewis et al., 1982).
Blastocyst Injections
Diploid or tetraploid blastocysts (94–98 h after HCG injection) were placed in
a drop of DMEM with 15% FCS under mineral oil. A flat-tip microinjection pi-
pette was used for iPS injections. Ten to fifteen injected blastocysts were
transferred to each uterine horn of 2.5 days post coitum pseudo-pregnant
B6D2F1 females. To recover full-term pups, recipient mothers were killed at
19.5 days post coitum. Surviving pups were fostered to lactating mothers.
Quantitative RT-PCR
B cell subsets were grown on OP-9 in cytokine conditioned media. OP9 cells
were depleted by pre-plating on gelatin coated plates before the cells were
harvested for mRNA preparation. Total RNA was isolated using Rneasy Kit
(QIAGEN). Onemicrogramof DNase treated RNAwas reverse transcribed using
aFirstStrandSynthesiskit (Invitrogen).QuantitativePCRanalysiswasperformed
in triplicate using 1/50 of the reverse transcription reaction in an ABI Prism 7000
(Applied Biosystems, Foster City, CA) with Platinum SYBR green qPCR Super-
Mix-UDG with ROX (Invitrogen). Gene expression analysis for ES markers was
performed by PCR using published primers (Takahashi and Yamanaka, 2006).
Flow Cytometry Analysis and Cell Sorting
The following fluorescently conjugated antibodies were used for FACS analy-
sis and cell sorting: anti-SSEA1 (R&D systems), anti-Igk, anti-Igl1,2,3, anti-CD19, anti-B220, anti-c-Kit, anti-CD25, anti-sIgM, anti-sIgD (all obtained
from BD-Biosciences). Cell sorting was performed by using FACS-Aria
(BD-Biosciences), and consistently achieved cell sorting purity of > 97%.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, thirteen figures, and two tables and can be found with
this article online at http://www.cell.com/cgi/content/full/133/2/250/DC1/.
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